Paul is a consultant with expertise in the fields of Catalysis, Design of Experiments, Principal Component Analysis and Process Development. Paul has a proven track record of the timely delivery of innovative solutions to projects resulting in significant reductions in costs and resources to customers. 

Paul worked as a Process Development Chemist at AstraZeneca and collaborated with academics at the University of Bristol to develop ligand property maps to enable the use of DoE for the efficient, rational development of catalytic reactions. Paul has 16 publications and 9 patents to date.